Corrigendum: RAB42 promotes glioma pathogenesis via the VEGF signaling pathway

Detalles Bibliográficos
Autores principales: Liu, Baoling, Su, Quanping, Xiao, Bolian, Zheng, Guodong, Zhang, Lizhong, Yin, Jiawei, Wang, Lijuan, Che, Fengyuan, Heng, Xueyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585971/
https://www.ncbi.nlm.nih.gov/pubmed/36276111
http://dx.doi.org/10.3389/fonc.2022.1034167
_version_ 1784813606783680512
author Liu, Baoling
Su, Quanping
Xiao, Bolian
Zheng, Guodong
Zhang, Lizhong
Yin, Jiawei
Wang, Lijuan
Che, Fengyuan
Heng, Xueyuan
author_facet Liu, Baoling
Su, Quanping
Xiao, Bolian
Zheng, Guodong
Zhang, Lizhong
Yin, Jiawei
Wang, Lijuan
Che, Fengyuan
Heng, Xueyuan
author_sort Liu, Baoling
collection PubMed
description
format Online
Article
Text
id pubmed-9585971
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-95859712022-10-22 Corrigendum: RAB42 promotes glioma pathogenesis via the VEGF signaling pathway Liu, Baoling Su, Quanping Xiao, Bolian Zheng, Guodong Zhang, Lizhong Yin, Jiawei Wang, Lijuan Che, Fengyuan Heng, Xueyuan Front Oncol Oncology Frontiers Media S.A. 2022-10-07 /pmc/articles/PMC9585971/ /pubmed/36276111 http://dx.doi.org/10.3389/fonc.2022.1034167 Text en Copyright © 2022 Liu, Su, Xiao, Zheng, Zhang, Yin, Wang, Che and Heng https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Liu, Baoling
Su, Quanping
Xiao, Bolian
Zheng, Guodong
Zhang, Lizhong
Yin, Jiawei
Wang, Lijuan
Che, Fengyuan
Heng, Xueyuan
Corrigendum: RAB42 promotes glioma pathogenesis via the VEGF signaling pathway
title Corrigendum: RAB42 promotes glioma pathogenesis via the VEGF signaling pathway
title_full Corrigendum: RAB42 promotes glioma pathogenesis via the VEGF signaling pathway
title_fullStr Corrigendum: RAB42 promotes glioma pathogenesis via the VEGF signaling pathway
title_full_unstemmed Corrigendum: RAB42 promotes glioma pathogenesis via the VEGF signaling pathway
title_short Corrigendum: RAB42 promotes glioma pathogenesis via the VEGF signaling pathway
title_sort corrigendum: rab42 promotes glioma pathogenesis via the vegf signaling pathway
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585971/
https://www.ncbi.nlm.nih.gov/pubmed/36276111
http://dx.doi.org/10.3389/fonc.2022.1034167
work_keys_str_mv AT liubaoling corrigendumrab42promotesgliomapathogenesisviathevegfsignalingpathway
AT suquanping corrigendumrab42promotesgliomapathogenesisviathevegfsignalingpathway
AT xiaobolian corrigendumrab42promotesgliomapathogenesisviathevegfsignalingpathway
AT zhengguodong corrigendumrab42promotesgliomapathogenesisviathevegfsignalingpathway
AT zhanglizhong corrigendumrab42promotesgliomapathogenesisviathevegfsignalingpathway
AT yinjiawei corrigendumrab42promotesgliomapathogenesisviathevegfsignalingpathway
AT wanglijuan corrigendumrab42promotesgliomapathogenesisviathevegfsignalingpathway
AT chefengyuan corrigendumrab42promotesgliomapathogenesisviathevegfsignalingpathway
AT hengxueyuan corrigendumrab42promotesgliomapathogenesisviathevegfsignalingpathway

Ejemplares similares